Zemplar Injection, Solution
Product Images NDC 0074-4637

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Zemplar (NDC 0074-4637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zemplar Injection Spl 01

Chemical structure of paricalcitol, the active ingredient in Zemplar injection solution. The diagram illustrates the molecular structure with carbon rings, hydroxyl groups, and other chemical bonds.*

FDA Label Image

Zemplar Injection Spl 02

Label for Zemplar (paricalcitol) injection, solution, 2 mcg/mL in a 1 mL single-dose vial. The label indicates intravenous use, manufactured in Ireland, and labeled by AbbVie Inc. Additional details include a discard instruction for unused portions and a barcode on the right side.*

FDA Label Image

Zemplar Injection Spl 03

Packaging label for Zemplar 2 mcg/mL (paricalcitol) injection, solution for intravenous use. The label notes single-dose vials with a 25 count of 1 mL vials. It is labeled as Rx only and manufactured by AbbVie Inc.*

FDA Label Image

Zemplar Injection Spl 04

Zemplar (paricalcitol) Injection 5 mcg/mL single-dose vial label. The label indicates it is for intravenous use, 1 mL volume, and packaged by AbbVie Inc. The product is noted as a human prescription drug with discard instructions for used portions.*

FDA Label Image

Zemplar Injection Spl 05

Packaging label for Zemplar 5 mcg/mL (paricalcitol) injection solution for intravenous use. The label indicates it contains 25 single-dose vials of 1 mL each. The product is Rx only and manufactured by AbbVie Inc. Label includes barcode and placeholder for lot, expiration, serial numbers, and 2D barcode.*

FDA Label Image

Zemplar Injection Spl 06

The label for Zemplar injection, containing paricalcitol, is shown for a 2 mL multi-dose vial with a concentration of 10 mcg per 2 mL (5 mcg/mL). The label indicates intravenous use and is manufactured by AbbVie Inc. It specifies that the product is for prescription use only.*

FDA Label Image

Zemplar Injection Spl 07

Packaging label for Zemplar paricalcitol injection, 10 mcg/2 mL (5 mcg/mL) multi-dose vials, 25 vials of 2 mL each. It is an intravenous solution labeled by AbbVie Inc. This box is marked Rx only and includes barcode, storage instructions, and batch identification placeholders.*

FDA Label Image

Zemplar Injection Spl 08

Packaging label for Zemplar (paricalcitol) Injection, 5 mcg/mL (10 mcg/2 mL) multiple-dose vials in 2 mL volume. The label states it is for intravenous use, manufactured by AbbVie Inc. Includes barcode and standard regulatory text on storage, usage, and manufacturing location.*

FDA Label Image

Zemplar Injection Spl 09

Label for Zemplar (paricalcitol) Injection, a multiple-dose vial containing 2 mL of solution at a strength of 10 mcg/2 mL (5 mcg/mL). The label notes it is for intravenous use, Rx only, and is manufactured by AbbVie Inc., North Chicago, IL, USA. The product is from Ireland.*

FDA Label Image

Zemplar Injection Spl 0a

Packaging label for Zemplar Paricalcitol Injection, 5 mcg/mL, single-dose vials, 2 mL x 1 vial, manufactured by AbbVie Inc. The label includes usage instructions for intravenous use, storage conditions, and disposal information. Bar code and product identification details are also visible.*

FDA Label Image

Zemplar Injection Spl 0b

Label for Zemplar paricalcitol injection, 5 mcg/mL strength in a 1 mL single-dose vial. The label states the product is for intravenous use, manufactured by AbbVie Inc., with a batch barcode and lot/expiration information area visible. It also notes to discard any unused portion.*

FDA Label Image

Zemplar Injection Spl 0c

Packaging label for Zemplar 2 mcg/mL (paricalcitol) injection, solution for intravenous use by AbbVie Inc. The label indicates single-dose vial packaging in 2.5 mL vials, with instructions to discard unused portions and aseptic technique recommendations. The label includes storage information and manufacturer details.*

FDA Label Image

Zemplar Injection Spl 0d

Label for Zemplar (paricalcitol) Injection 2 mcg/mL single-dose vial. The product is intended for intravenous use and supplied in a 1 mL vial. Labeled by AbbVie Inc., manufactured in Ireland, and marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.